Zytiga 250mg Tablet

Side effects are possible with any medications; not everyone will experience them. Side effects of Zytiga 250mg are as follows:

• ​Swelling of a joint
  
• General discomfort
  
• Low potassium levels in the blood (may cause muscle weakness, twitches, or pounding heartbeat)
  
• Swelling (legs, feet, or other areas)
  
• Frequent urination at night
  
• Indigestion
  
• Muscle pain
  
• Fluid buildup in legs or feet
  
• High blood pressure
  
• Urinary tract infection
  
• Diarrhea
  
• High fat levels in the blood (dyslipidemia)
  
• Chest pain
  
• Irregular heartbeat
  
• Rapid heart rate
  
• Bone fracture
  
• Blood in urine
  
• Rash

• Always follow your doctor's instructions while taking Zytiga 250mg Tablets. The medication must be taken orally. Food should not be consumed with it. Avoid breaking the tablets by swallowing them whole with water.
• You should eat at least 2 hours before taking the medicine and avoid food for 1 hour afterward. Pregnant or potentially pregnant women should not handle this medicine without gloves.
  

• By preventing the production of testosterone, which promotes the growth of prostate cancer cells, Zytiga 250mg Tablet is mainly used to treat metastatic castration-resistant prostate cancer (mCRPC).
•  By inhibiting the CYP17 enzyme, it lowers the amount of testosterone and other androgens produced by the testes, adrenal glands, and even cancer cells. 
• This decrease in androgen levels increases survival chances, slows the course of the disease, and improves the patient's quality of life in general.
•  It reduces adverse effects such fluid retention and hypertension when taken with prednisone, improving patient outcomes and tolerability.

• Zytiga (abiraterone acetate) is used in adult men to treat advanced prostate cancer that has spread, often together with prednisone to reduce side effects. Always pair it with prednisone to prevent adrenal insufficiency.
• Take this medicine as prescribed by your doctor, once daily on an empty stomach; food can increase medicine levels.
  
• It may be combined with testosterone-lowering treatment in earlier stages of prostate cancer.
• Serious risks include adrenal insufficiency, liver toxicity, heart problems, and bone fractures; regular monitoring is essential.
• Liver function tests are required before starting the treatment and then regularly.
• This medicine is not for women or children; men must use contraceptives during treatment and after stopping.
• Inform your doctor if you have liver problems, heart disease, high blood pressure, diabetes, allergies, or low potassium.
• Tell your doctor about all medicines, supplements, and herbal products you are taking.
• Do not take Zytiga with Ra-223 (another prostate cancer treatment).
• Since it contains lactose and sodium, let your doctor know if you have lactose intolerance or are on a salt-restricted diet
  

• Attard, G., Reid, A. H. M., A’Hern, R., Parker, C. C., et al. (2012). Open‑label, Phase I pharmacokinetic studies of abiraterone acetate in healthy men: a dose‑escalation and dose‑proportionality study. Clinical Cancer Research, 18(7), 110. https://pubmed.ncbi.nlm.nih.gov/22526411/
• Li, Y., Zhao, X., Wang, Q., et al. (2018). Pharmacokinetics and bioequivalence of a generic versus branded Abiraterone acetate 250 mg tablet: single‑dose, open‑label, replicate‑design in healthy Chinese male volunteers. Journal of Clinical Pharmacology, 170. https://pubmed.ncbi.nlm.nih.gov/30535959/
• Liu, Y., Li, Y., Xu, P., Shen, Y., Tang, B., & Wang, Q. (2022). Development of abiraterone acetate nanocrystal tablets to enhance oral bioavailability: formulation optimization, https://pubmed.ncbi.nlm.nih.gov/35745707/
• characterization, in vitro dissolution, and pharmacokinetic evaluation. Pharmaceutics, 14(6), 1134.